Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study

This is the latest version of this eprint.

Pujades-Roderiguez, M, Morgan, AW orcid.org/0000-0003-1109-624X, Cubbon, RM orcid.org/0000-0001-7844-3600 et al. (1 more author) (2020) Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Medicine, 17 (12). e1003432. ISSN 1549-1277

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2020 Pujades-Rodriguez et al. This is an open access article under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/)

Dates:
  • Accepted: 29 October 2020
  • Published (online): 3 December 2020
  • Published: 3 December 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Dentistry (Leeds) > Applied Health and Clinical Translation (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Funding Information:
Funder
Grant number
MRC (Medical Research Council)
MR/N011775/1
F. Hoffman La Roche Ltd
WA40984
Depositing User: Symplectic Publications
Date Deposited: 07 Oct 2020 13:20
Last Modified: 14 Feb 2025 15:39
Status: Published
Publisher: Public Library of Science
Identification Number: 10.1371/journal.pmed.1003432
Open Archives Initiative ID (OAI ID):

Available Versions of this Item

Download

Export

Statistics